Welcome to our dedicated page for Quantum Computing SEC filings (Ticker: QUBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum Computing Inc. filings document the company’s Nasdaq-listed common stock, quantum optics and integrated photonics business, governance matters and material corporate events. Current reports cover operating and financial results, material agreements, capital-structure disclosures, acquisitions or dispositions, executive appointments and related exhibits.
Proxy materials address annual meeting procedures, board matters, compensation arrangements and shareholder voting. The filing record also documents the completed acquisition of Luminar Semiconductor, including transaction reporting and supplemental financial statements, alongside disclosures about QCi’s TFLN foundry services, photonic-chip manufacturing, quantum machines and product areas in AI, high-performance computing, cybersecurity and remote sensing.
Quantum Computing Inc. filed an amended report to add full financial statements and unaudited pro forma data for its acquisition of Luminar Semiconductor, Inc. (LSI). The company agreed to buy all LSI shares for a cash purchase price of $110.0 million, adjusted to $108.5 million, with $97.5 million paid at closing and $11.0 million held in escrow until February 2, 2027. Preliminary purchase accounting assigns $86.5 million to goodwill and $13.5 million to intangible assets. LSI generated $29.8 million of 2025 revenue and a net loss of $11.8 million, while the pro forma combined 2025 revenue is $30.5 million with a net loss of $32.0 million. LSI had total assets of $29.4 million and a stockholders’ deficit of $60.8 million as of December 31, 2025.
Weimer Carl Scott reported acquisition or exercise transactions in this Form 4 filing.
Quantum Computing Inc. director Weimer Carl Scott received a grant of 22,123 shares of common stock as restricted stock units valued at $6.78 per share under the company’s 2022 Equity and Incentive Plan. These RSUs are compensation, not an open-market purchase.
The footnote states that one quarter of the RSUs vest immediately, with additional quarters vesting on June 30, 2026, September 30, 2026, and December 31, 2026, subject to his continued service. Following this grant, he directly holds 22,123 shares.
TURMELLE MICHAEL C reported acquisition or exercise transactions in this Form 4 filing.
Quantum Computing Inc. director Michael C. Turmelle received an equity grant of 22,123 shares of Common Stock in the form of restricted stock units (RSUs) valued at $6.78 per share. Following the grant, he holds 22,123 shares directly.
The RSUs were issued under the Quantum Computing Inc. 2022 Equity and Incentive Plan. According to the vesting schedule, one quarter of the RSUs vests immediately. The remaining three quarters vest in equal portions on June 30, 2026, September 30, 2026 and December 31, 2026, subject to his continuous service through each date.
Shabani Javad reported acquisition or exercise transactions in this Form 4 filing.
Quantum Computing Inc. director Shabani Javad reported an equity compensation grant in the form of restricted stock units (RSUs) for 22,123 shares of Common Stock at $6.78 per share.
According to the grant terms, one quarter of the RSUs vests immediately, with additional quarters vesting on June 30, 2026, September 30, 2026, and December 31, 2026, subject to Javad’s continuous service. After this award, Javad directly holds 22,123 shares reported in this filing.
Schwartz Eric Mark reported acquisition or exercise transactions in this Form 4 filing.
Quantum Computing Inc. director Eric Mark Schwartz received an award of 22,123 restricted stock units (RSUs) of common stock at $6.78 per share. These RSUs were granted under the Quantum Computing Inc. 2022 Equity and Incentive Plan.
According to the vesting schedule, one quarter of the RSUs vests immediately on grant, with additional quarters vesting on June 30, 2026, September 30, 2026, and December 31, 2026, in each case conditioned on his continuous service through the applicable vesting date. Following this grant, he holds 22,123 shares directly.
FAGENSON ROBERT B reported acquisition or exercise transactions in this Form 4 filing.
Quantum Computing Inc. director Robert B. Fagenson received a grant of 22,123 shares of Common Stock in the form of restricted stock units (RSUs) valued at $6.78 per share. These are compensation-related awards, not open-market share purchases.
According to the vesting schedule, one quarter of the RSUs vest immediately, with additional quarters vesting on June 30, 2026, September 30, 2026, and December 31, 2026, subject to his continuous service through each vesting date. Following the grant, he holds 22,123 shares directly.
Quantum Computing Inc: The Vanguard Group filed Amendment No. 2 to a Schedule 13G/A stating it beneficially owns 0 shares of Common Stock (0%). The filing explains an internal realignment effective 01/12/2026 under SEC Release No. 34-39538, causing certain subsidiaries to report separately.
Quantum Computing Inc. CFO and General Counsel Christopher Bruce Roberts exercised employee stock options for 400,000 shares of common stock at an exercise price of $6.85 per share. He then sold a total of 78,262 shares of common stock in open-market transactions at weighted-average prices around $7.85 per share.
According to the disclosure, these sales were made to cover the option exercise price, withholding tax obligations, and broker fees and commissions through a broker-assisted cashless exercise of options originally granted on April 26, 2021 under the 2019 Equity and Incentive Plan. After these transactions, Roberts directly holds 1,123,038 shares of common stock and 300,000 remaining stock options.
Quantum Biotechnologies (QUBT) filing to sell 9,360 shares. The Form 144 reports the intended sale of 9,360 shares following an exercise of options under a registered plan dated 03/11/2026. The filing also shows prior sales of 68,902 shares on 03/10/2026.
Morgan Stanley Smith Barney LLC filed a Form 144 reporting the proposed sale of 68,902 shares of Common Stock via the exercise of options under a registered plan on 03/10/2026. The filing identifies NASDAQ and lists the transaction date as 03/10/2026.